Moxifloxacin Film-Coated Tablets (400 mg)

Healthy Inc is a specialized global supplier and exporter of advanced anti-infective, pulmonology, and critical-care therapeutics. We provide ultra-high-purity, kinetically optimized Moxifloxacin (as Hydrochloride) Film-Coated Tablets (400 mg), manufactured in WHO–GMP certified, high-precision oral solid dosage facilities. This “Advanced Respiratory Fluoroquinolone” is a massive-volume, highly lucrative export to infectious disease centers, respiratory clinics, emergency hospital networks, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, heavy-duty intervention for severe Community-Acquired Pneumonia (CAP), complicated intra-abdominal infections, and acute exacerbations of chronic bronchitis.

Product Overview

This highly advanced 4th-generation fluoroquinolone formulation is engineered to eradicate the most stubborn and resistant respiratory pathogens. Unlike older fluoroquinolones, it provides unparalleled coverage against anaerobic bacteria and “atypical” pneumonia pathogens, delivering hospital-grade intravenous efficacy in a convenient oral tablet.

The “DNA-Shredding Respiratory” Specialist:

• Mechanism 1 (The Dual-Enzyme Blockade): Moxifloxacin aggressively penetrates bacterial cells and targets their genetic core. It specifically binds to and inhibits DNA gyrase (topoisomerase II) and Topoisomerase IV—the essential enzymes required for bacterial DNA to uncoil, replicate, and repair. By simultaneously locking both of these enzymes, it physically shatters the bacterial DNA strands, resulting in rapid, bactericidal cell death.
• Mechanism 2 (The “Atypical” & Anaerobic Advantage): Older generation drugs (like Ciprofloxacin) are weak against Gram-positive and anaerobic bacteria. Moxifloxacin features a specialized bulky methoxy functional group that forcefully blocks bacterial efflux pumps (the mechanism bacteria use to spit the drug out). This grants it massive, lethal coverage against Streptococcus pneumoniae (including penicillin-resistant strains), Mycoplasma, Chlamydia, and severe anaerobic gut pathogens.
• The Once-Daily Compliance Factor: Moxifloxacin possesses a long half-life and massive tissue penetration, allowing for a highly convenient, once-daily 400 mg dosing regimen. This ensures maximum patient compliance and rapid clinical cure rates in outpatient settings, preventing costly hospital readmissions.

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Infectious Disease Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Photolabile Shielding & High-Shear Granulation: Generating a rapid onset of action with a dense 400 mg fluoroquinolone payload requires elite manufacturing controls. Our facilities utilize advanced high-shear wet granulation integrated with high-performance superdisintegrants to ensure immediate gastric dissolution. Furthermore, to protect the light-sensitive API, tablets are coated with a specialized opaque titanium-dioxide film and immediately sealed in heavy-gauge Alu-Alu, ensuring maximum shelf-life and clinical efficacy.

Therapeutic Indications (Human Use)

Indicated for the targeted, highly aggressive management of severe bacterial infections:

• Community-Acquired Pneumonia (CAP): Eradication of multi-drug resistant Streptococcus pneumoniae and atypical pathogens.
• Complicated Skin and Skin Structure Infections (cSSSI): Treatment of severe deep-tissue infections, including MRSA in certain regions.
• Complicated Intra-Abdominal Infections (cIAI): First-line monotherapy for severe mixed aerobic/anaerobic abdominal infections.
• Acute Bacterial Sinusitis & Exacerbations of Chronic Bronchitis: When other frontline antibiotics have failed or cannot be used.

Dosage & Administration

Recommended Dosage (Strictly as per Infectious Disease Guidelines):

• Standard Adult Dosing: 400 mg taken orally once daily. Duration ranges from 5 to 14 days depending on the severity and site of infection.
• Administration: Must be taken with a full glass of water. Can be taken with or without food.
• Antacid & Dairy Warning: Moxifloxacin binds heavily to multivalent cations (calcium, magnesium, iron, zinc). Tablets must be taken at least 4 hours before or 8 hours after dairy products, antacids, sucralfate, or vitamin supplements, as these will completely block the antibiotic’s absorption.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• BLACK BOX WARNING (Tendon Rupture & Neuropathy): Fluoroquinolones are associated with disabling and potentially irreversible serious adverse reactions, including spontaneous tendon rupture (especially the Achilles tendon), peripheral neuropathy, and severe central nervous system effects (hallucinations, anxiety, seizures). Discontinue immediately at the first sign of tendon pain or neurological symptoms.
• BLACK BOX WARNING (Myasthenia Gravis): May exacerbate muscle weakness in persons with myasthenia gravis. Avoid use in patients with known history.
• QTc Prolongation & Fatal Arrhythmia: Moxifloxacin significantly prolongs the QT interval on an EKG. It is strictly contraindicated in patients with uncorrected hypokalemia or those taking Class IA or III antiarrhythmics, as it can trigger fatal Torsades de Pointes.
• Hepatotoxicity & Clostridioides difficile: Can cause severe liver injury and life-threatening C. difficile-associated pseudomembranous colitis.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Infectious Disease Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antibiotics and Respiratory Formulations. Whether you are looking for a reliable Government Tender Supplier for pneumonia protocols in Africa or a B2B Pharma Marketplace partner for Latin America, our highly regulated logistics network ensures timely, secure delivery of WHO-GMP certified products.